Manulife (Manufacturers Life Insurance)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-836
| Closed | -$3K | – | 4304 |
|
2018
Q2 | $3K | Sell |
836
-10,701
| -93% | -$38.4K | ﹤0.01% | 4188 |
|
2018
Q1 | $73K | Buy |
11,537
+7,695
| +200% | +$48.7K | ﹤0.01% | 3485 |
|
2017
Q4 | $31K | Sell |
3,842
-10,682
| -74% | -$86.2K | ﹤0.01% | 3682 |
|
2017
Q3 | $166K | Buy |
14,524
+132
| +0.9% | +$1.51K | ﹤0.01% | 3124 |
|
2017
Q2 | $141K | Buy |
14,392
+1,854
| +15% | +$18.2K | ﹤0.01% | 3250 |
|
2017
Q1 | $304K | Buy |
12,538
+1,719
| +16% | +$41.7K | ﹤0.01% | 2539 |
|
2016
Q4 | $347K | Buy |
10,819
+71
| +0.7% | +$2.28K | ﹤0.01% | 2372 |
|
2016
Q3 | $537K | Buy |
10,748
+188
| +2% | +$9.39K | ﹤0.01% | 2036 |
|
2016
Q2 | $448K | Buy |
10,560
+835
| +9% | +$35.4K | ﹤0.01% | 2106 |
|
2016
Q1 | $623K | Buy |
9,725
+668
| +7% | +$42.8K | ﹤0.01% | 1854 |
|
2015
Q4 | $563 | Hold |
9,057
| – | – | ﹤0.01% | 1952 |
|
2015
Q3 | $606 | Buy |
9,057
+245
| +3% | +$16 | ﹤0.01% | 1878 |
|
2015
Q2 | $857 | Buy |
8,812
+563
| +7% | +$55 | ﹤0.01% | 1778 |
|
2015
Q1 | $771 | Buy |
8,249
+300
| +4% | +$28 | ﹤0.01% | 1821 |
|
2014
Q4 | $707 | Sell |
7,949
-286
| -3% | -$25 | ﹤0.01% | 1782 |
|
2014
Q3 | $569 | Buy |
8,235
+221
| +3% | +$15 | ﹤0.01% | 1909 |
|
2014
Q2 | $460K | Sell |
8,014
-1,434
| -15% | -$82.3K | ﹤0.01% | 2092 |
|
2014
Q1 | $374 | Sell |
9,448
-307
| -3% | -$12 | ﹤0.01% | 2278 |
|
2013
Q4 | $410 | Buy |
9,755
+691
| +8% | +$29 | ﹤0.01% | 2191 |
|
2013
Q3 | $271 | Sell |
9,064
-405
| -4% | -$12 | ﹤0.01% | 2426 |
|
2013
Q2 | $501K | Buy |
+9,469
| New | +$501K | ﹤0.01% | 1894 |
|